新生儿脑病:通过基因组测序识别的新型表型和基因型
Anastasia Ambrose1, Vanda McNiven2, Diane Wilson3
1Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Neurology. Genetics
|January 15, 2025
概括
基因组测序确定了新生儿脑病变 (NE) 的遗传原因,这是一种影响新生儿意识的疾病. 这项研究发现,41%的病例具有遗传诊断,扩大了对NE相关基因的理解.
科学领域:
- 遗传学 遗传学 是一个
- 新生儿医学 新生儿医学
- 基因组分析 基因组分析
背景情况:
- 新生儿脑病变 (NE) 影响1-6/1000名活产新生儿,表现为意识变化或发作.
- 研究NE的遗传基础对于诊断和了解疾病机制至关重要.
研究的目的:
- 使用基因组测序 (GS) 识别新生儿新生儿脑病变 (NE) 的遗传原因.
主要方法:
- 基因组测序 (GS) 在17名患有NE的新生儿及其父母身上进行 (三组分析).
- 生物信息管道,in silico预测工具,蛋白质3D建模和功能表征被用于评估变异性病原性.
- 开发了手动过器和特定的分析工具来分析测序数据.
主要成果:
- 在17名新生儿身上发现了10个基因中的12种变异.
- 在已知的疾病基因 (PPP2R5D,BCOR,CFL2,SCN2A) 中发现了四种致病性/可能致病性变异.
- 在已知和候选基因 (DST,STAB2,CELF4,SORCS2,CTNND2,ASTN1) 中发现了七种不确定的变异 (VUS). 功能性特征证实了SORCS2 VUS和重新分类的STAB2变体的致病性.
结论:
- 在这项前性研究中,基因组测序实现了41%的NE诊断率.
- 这项研究扩大了几种已知的遗传综合征的表型谱,包括NE.
- 三个候选基因 (SORCS2,CELF4,ASTN1) 被确定为NE的潜在原因,突出了功能特征和蛋白质建模在遗传发现中的重要性.
更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.3K
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.6K
相关概念视频
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...